Discrete Series

Actos rose to prominence years after the leading diabetes medication, Avandia, was conclusively linked to increased risks of heart attack, stroke and other forms of cardiovascular disease. Despite numerous FDA warnings and even a US Senate Finance Committee inquiry, the drug was allowed to remain on the market, ultimately causing more than 83,000 heart attacks and tens of thousands of deaths. As Avandia began to be prescribed less, the drug Actos quickly gained market share, despite the very first tests of the drug showing an increased risk of Actos bladder cancer. Now the FDA has issued a safety warning about bladder cancer and Actos has been recalled in France, also because of the bladder cancer risk. Actos was approved the FDA in 1999 and has been used well over two million people during some of its peak years. More research is being done about Actos and bladder cancer in those that have taken the drug, but in the meantime, just how worried do people taking Actos need to be about bladder cancer? Read more at www.actosbladdercancerlawsuits.com.